Advancements in manufacturing technologies is a key driver driving nucleic acid therapeutics CDMO market revenue growth.

Analysis of Nucleic Acid Extraction System Market Covering 30 Countries Including Analysis of US, Canada, UK, Germany, France, Nordics, GC ...

Innovative Research to Advance Oligonucleotide Therapeutics now published in the Journal of Nucleic Acid Therapeutics News provided by Rockland Immunochemicals, Inc.

Nucleic acid therapeutics, which involve transferring exogenous genes inside target cells, are a promising clinical treatment option that can regulate gene expression at the transcriptional or ...

Dale Patterson, Ph.D. is Vice President and General Manager of Molecular Biology and Nucleic Acid Therapeutics at Thermo Fisher Scientific.When Covid-19 emerged, the Nucleic Acid Therapeutics team ...

Nucleic Acid Therapeutics is an authoritative, peer-reviewed journal published bimonthly in print and online that focuses on cutting-edge basic research, therapeutic applications, and drug ...

Alloy’s genetic medicines group is led by Vinod Vathipadiekal, PhD, who has held research leadership roles across RNA and nucleic acid therapeutics programs at biotech and pharma companies.

Next Generation Vaccines with Spherical Nucleic Acids (SNAs) from AZoNetwork on Vimeo. At Pittcon 2018, you presented three structural SNAs that had the differing anti-tumor efficiencies.

More information: NANOSPRESSO: toward personalized, locally produced nucleic acid nanomedicines, Frontiers in Science (2025). DOI: 10.3389/fsci.2025.1458636 Provided by Frontiers ...

Dublin, April 17, 2020 (GLOBE NEWSWIRE) -- The "Nucleic Acid Based Gene Therapy Market Global Report 2020-30" report has been added to ResearchAndMarkets.com's offering. The global nucleic acid ...

Determining the critical quality attributes (CQAs) of emerging, more complex nucleic acid (NA) therapeutics and their carrier systems poses a new challenge for biopharmaceutical companies.

If possible, targeting noncanonical nucleic acid structures with PNAs would increase the chance of developing novel therapeutics that can target all genomic DNA and RNA structures in genes and ...